Intersociety Radiation Oncology Summit—SCOPE II
| Autor: | Louis B. Harrison, Robyn L. Watson, K. Kian Ang, Paula J. Schomberg, Laura I. Thevenot, Francine Halberg, Prabhakar Tripuraneni, Anthony L. Zietman, Phillip M. Devlin, Patricia J. Eifel, Tom Pickles, Bruce G. Haffty, Christopher G. Willett |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Cancer Research
medicine.medical_specialty geography Radiation Scope of practice Summit geography.geographical_feature_category Scope (project management) business.industry medicine.medical_treatment Organizational culture Cancer treatment Radiation therapy Oncology Radiation oncology Medicine Radiology Nuclear Medicine and imaging Medical physics business Pace |
| Zdroj: | International Journal of Radiation Oncology*Biology*Physics. 72:323-326 |
| ISSN: | 0360-3016 |
| DOI: | 10.1016/j.ijrobp.2008.06.1904 |
| Popis: | In 1999, with direction from the American Society for TherapeuticRadiology andOncology(ASTRO) BoardofDirectors, a Steering Committee and a series of subcommittees were formed to define the scope of practice within radiation oncology. During the next several years, meetings were convened and drafts were developed to include input from the ASTRO Board of Directors, other experts within the oncology field, and the ASTRO members themselves. The result of this work was The Report of the ASTRO Working Group on the Scope of Radiation Oncology (from here on referred to as the SCOPE I Report).Thisreport‘‘outlined the current roleofRadiation Oncology and highlighted a number of issues and recommendations potentially important in preserving and enhancing the relevance and value of radiation oncology’’ (1). The SCOPE I Report illustrated issues pertaining to the amount of clinical involvement radiation oncologists have with patients and its effect on patient care. It addressed combined-modality therapy and its place within radiation oncology. The role of radiation therapy in treating nonmalignant (benign) diseases was also explored. The SCOPE I Report also discussed the knowledge and skill required to keep up with the fast pace of technologic advancement within radiation oncology. The purpose of the SCOPE I Report was to ‘‘stimulate dialogue and move the community toward development of an action plan’’ (1). Unfortunately, little action resulted from the development of this document. Today, many within radiation oncology believe that their field is at a crossroad in its path to the future, and that the choices made today will determine its future role in cancer treatment. Radiation oncology has become increasingly technologically driven, affecting both the way patients are managed and the way other oncology specialties view and behave toward it. For these reasons, ASTRO convened the |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|